Canada markets closed

Marvel Biosciences Corp. (MRVL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.11500.0000 (0.00%)
At close: 10:35AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 4.58M
Enterprise Value 5.86M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)226.82
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 327.78%
S&P500 52-Week Change 324.16%
52 Week High 30.1900
52 Week Low 30.0100
50-Day Moving Average 30.1145
200-Day Moving Average 30.1110

Share Statistics

Avg Vol (3 month) 346.93k
Avg Vol (10 day) 311.15k
Shares Outstanding 539.79M
Implied Shares Outstanding 639.79M
Float 833.21M
% Held by Insiders 129.60%
% Held by Institutions 10.00%
Shares Short (Jun 28, 2024) 45k
Short Ratio (Jun 28, 2024) 40.16
Short % of Float (Jun 28, 2024) 4N/A
Short % of Shares Outstanding (Jun 28, 2024) 40.01%
Shares Short (prior month Apr 30, 2024) 41.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Apr 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-153.64%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-2.1M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)217.69k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.5M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.22
Book Value Per Share (mrq)-0.07

Cash Flow Statement

Operating Cash Flow (ttm)-1.28M
Levered Free Cash Flow (ttm)-430.67k